Bone marrow edema (BME) is when normal fatty bone marrow—the spongy tissue in the center of bones—is replaced with a watery mix of fluid and blood. Also known as a bone marrow lesion, BME occurs when arthritis, an injury, or a fracture damages the normal bone structure.
Water on the knee is when fluid collects around and inside the knee joint, causing pain and swelling. Also known as knee effusion or fluid on the knee, it can occur whenever there's damage to the joint due to injury or underlying disease, such as arthritis.
For patients with symptomatic, radiographic, moderate-to-severe osteoarthritis or osteonecrosis of the hip or knee, total joint arthroplasty (TJA) should not be delayed in order to pursue additional nonoperative treatments.
Short term outcomes (average follow up of 2.4 years) of a constrained acetabular liner in primary and revision total hip arthroplasty.
As instability continues to be a burden post total hip arthroplasty (THA), there has been a controversial discussion on the ideal implant choice. We report here the outcomes of a modern constrained acetabular liner (CAL) system in primary and revision THA at an average follow up of 2.4 years.
Patients With Knee Osteoarthritis Who Receive Platelet-Rich Plasma or Bone-Marrow Aspirate Concentrate Injections Have Better Outcomes Than Patients Who Receive Hyaluronic Acid: Systematic Review and Meta-analysis
To systematically review the literature in order to compare the efficacy and safety of platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and hyaluronic acid (HA) injections for the treatment of knee osteoarthritis (OA).